Solve Therapeutics

Developer of antibody-based therapies targeting tumor-specific antigens for cancer treatment

placeSan Diego, California, United States calendar_todayFounded 2021 language solvetx.com

Innovation

16 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 269 times.

YearFilings
20244
20258
20269

Social engagement

Social engagement: 2.4K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Yosemite.

Investor typeCountShare
Venture capital433%
Private equity217%
Other / undisclosed650%
Coming soon